Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-017361

Options or other derivatives

  • Director acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-03-05 Grant or award : show line 1 in the form Nonstatutory Stock Option (right to buy) +50,000 $26.12 2030-03-04 50,000 50,000 D
Loading xslF345X03/doc4.xml…